Biomaterial Database

The cost of rejection in liver allograft recipients. 1998

J E Martin, and P Fleck, and T J Schroeder, and J F Whiting, and D W Hanto

Department of Pharmacy Services, University of Cincinnati Hospital, OH 45267-0740, USA.

UI	MeSH Term	Description	Entries
D007166	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.	Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007297	Inpatients	Persons admitted to health facilities which provide board and room, for the purpose of observation, care, diagnosis or treatment.	Inpatient
D009820	Ohio	State bounded on the north by Michigan and Lake Erie, on the east by Ohio River and Pennsylvania, on the south by Ohio River, and on the west by Indiana.
D010045	Outpatients	Persons who receive ambulatory care at an outpatient department or clinic without room and board being provided.	Out-patients,Out patients,Out-patient,Outpatient
D003365	Costs and Cost Analysis	Absolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs.	Affordability,Analysis, Cost,Cost,Cost Analysis,Cost Comparison,Cost Measures,Cost-Minimization Analysis,Costs and Cost Analyses,Costs, Cost Analysis,Pricing,Affordabilities,Analyses, Cost,Analyses, Cost-Minimization,Analysis, Cost-Minimization,Comparison, Cost,Comparisons, Cost,Cost Analyses,Cost Comparisons,Cost Measure,Cost Minimization Analysis,Cost, Cost Analysis,Cost-Minimization Analyses,Costs,Measure, Cost,Measures, Cost
D006084	Graft Rejection	An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.	Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189	Retrospective Studies	Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.	Retrospective Study,Studies, Retrospective,Study, Retrospective
D016031	Liver Transplantation	The transference of a part of or an entire liver from one human or animal to another.	Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver

Related Publications

J E Martin, and P Fleck, and T J Schroeder, and J F Whiting, and D W Hanto

Late acute rejection occurring in liver allograft recipients.

October 1996, Canadian journal of gastroenterology = Journal canadien de gastroenterologie,

J E Martin, and P Fleck, and T J Schroeder, and J F Whiting, and D W Hanto

Allograft rejection in pediatric recipients of living related liver transplants.

January 1996, Hepatology (Baltimore, Md.),

J E Martin, and P Fleck, and T J Schroeder, and J F Whiting, and D W Hanto

Indications for tacrolimus anti-rejection therapy in liver allograft recipients.

January 1996, Transplant international : official journal of the European Society for Organ Transplantation,

J E Martin, and P Fleck, and T J Schroeder, and J F Whiting, and D W Hanto

The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients.

December 2004, Transplantation proceedings,

J E Martin, and P Fleck, and T J Schroeder, and J F Whiting, and D W Hanto

The natural history of untreated focal allograft rejection in liver transplant recipients.

March 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,

J E Martin, and P Fleck, and T J Schroeder, and J F Whiting, and D W Hanto

Soluble interleukin 2 receptor level in liver allograft recipients: an indicator of rejection.

February 1989, Transplantation proceedings,

J E Martin, and P Fleck, and T J Schroeder, and J F Whiting, and D W Hanto

Sequential IL-2 and IL-2R levels predict rejection in liver allograft recipients.

February 1991, Transplantation proceedings,

J E Martin, and P Fleck, and T J Schroeder, and J F Whiting, and D W Hanto

Chronic rejection of the liver allograft.

June 1993, Gastroenterology clinics of North America,

J E Martin, and P Fleck, and T J Schroeder, and J F Whiting, and D W Hanto

Intrathymic microchimerism predicts rejection response in allograft recipients.

January 1997, Transplantation proceedings,